{"id":"https://openalex.org/W2104757635","doi":null,"title":"Topiramate induced bilateral angle-closure glaucoma.","display_name":"Topiramate induced bilateral angle-closure glaucoma.","publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W2104757635","mag":"2104757635","pmid":"https://pubmed.ncbi.nlm.nih.gov/18604026"},"language":"en","primary_location":{"id":"pmid:18604026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18604026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kathmandu University medical journal (KUMJ)","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001953141","display_name":"Sanjay Kumar Singh","orcid":"https://orcid.org/0000-0003-2448-6765","observed_orcids":["https://orcid.org/0000-0003-2448-6765"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S K Singh","raw_affiliation_strings":["Mechi Eye Care Centre, Birtamod, Jhapa, Nepal. sanjaysinghnepal@yahoo.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mechi Eye Care Centre, Birtamod, Jhapa, Nepal. sanjaysinghnepal@yahoo.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"S S Thapa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S S Thapa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111890099","display_name":"B P Badhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B P Badhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"5","issue":"2","first_page":"234","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11929","display_name":"Cerebral Venous Sinus Thrombosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":1.0},{"id":"https://openalex.org/keywords/angle-closure-glaucoma","display_name":"angle-closure glaucoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/drug-induced-glaucoma","display_name":"drug-induced glaucoma","score":0.9179999828338623},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7509999871253967},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8539999723434448},{"id":"https://openalex.org/keywords/atropine","display_name":"atropine","score":0.6000000238418579},{"id":"https://openalex.org/keywords/glaucoma-medications","display_name":"glaucoma medications","score":0.7279999852180481},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2777683783","wikidata":"https://www.wikidata.org/wiki/Q221174","display_name":"Topiramate","level":3,"score":0.9908614754676819},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9394986629486084},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.7766536474227905},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.6847074031829834},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5376141667366028},{"id":"https://openalex.org/C2775859210","wikidata":"https://www.wikidata.org/wiki/Q26272","display_name":"Atropine","level":2,"score":0.5302289128303528},{"id":"https://openalex.org/C2909822487","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Angle-closure glaucoma","level":3,"score":0.5046950578689575},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5010280609130859},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.09019675850868225},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.056548506021499634}],"mesh":[{"descriptor_ui":"D000077236","descriptor_name":"Topiramate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005632","descriptor_name":"Fructose","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015812","descriptor_name":"Glaucoma, Angle-Closure","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D015812","descriptor_name":"Glaucoma, Angle-Closure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:18604026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18604026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kathmandu University medical journal (KUMJ)","raw_type":"Case Reports"},{"id":"mag:2104757635","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18604026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1491237285","https://openalex.org/W1601842922","https://openalex.org/W1966532240","https://openalex.org/W2026080368","https://openalex.org/W2093392404","https://openalex.org/W2157909788","https://openalex.org/W4417062839"],"related_works":["https://openalex.org/W7100568756","https://openalex.org/W1974163881","https://openalex.org/W2778106803","https://openalex.org/W2036193513","https://openalex.org/W1991990077","https://openalex.org/W2618371496","https://openalex.org/W2083259793","https://openalex.org/W4288712242","https://openalex.org/W4402319964","https://openalex.org/W4286843096"],"abstract_inverted_index":{"Topiramate":[0],"is":[1,6,31,46],"a":[2,18],"sulfamate-substituted":[3],"monosaccharide":[4],"and":[5,67,80],"used":[7,16],"as":[8,17],"an":[9],"antiepileptic":[10],"medication.":[11],"It":[12],"can":[13],"also":[14],"be":[15],"prophylactic":[19],"agent":[20],"for":[21],"headache":[22],"from":[23],"migraine.":[24],"The":[25],"main":[26],"purpose":[27],"of":[28,43,51],"this":[29],"article":[30],"to":[32],"create":[33],"awareness":[34],"among":[35],"medical":[36],"colleagues":[37],"regarding":[38],"severe":[39],"ophthalmic":[40],"side":[41],"effect":[42],"topiramate.":[44],"This":[45,59],"the":[47],"first":[48],"reported":[49],"case":[50,60],"topiramate":[52,66],"induced":[53],"bilateral":[54],"angle-closure":[55],"glaucoma":[56],"in":[57],"Nepal.":[58],"was":[61],"managed":[62],"successfully":[63],"by":[64,68],"discontinuing":[65],"starting":[69],"anti-glaucoma":[70],"medication":[71],"along":[72],"with":[73],"atropine":[74],"eye":[75],"drops":[76],"which":[77],"were":[78],"tapered":[79],"eventually":[81],"discontinued.":[82]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}